Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Magnetoencephalography biomarkers for assessing myelin content and neuronal function in acute optic neuritis.

Brain communications·2026
Same author

Bispecific antibody therapy in multiple myeloma and risk of progressive multifocal leukoencephalopathy.

Blood advances·2026
Same author

Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).

Neurology·2026
Same author

French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

Neurology·2026
Same author

Rethinking prognosis in multiple sclerosis: a multiaxial perspective.

Nature reviews. Neurology·2026

Related Experiment Video

Updated: Apr 15, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.2K

Advanced imaging tools to investigate multiple sclerosis pathology.

Benedetta Bodini1, Céline Louapre2, Bruno Stankoff3

  • 1Sorbonne Universités, UPMC Université Paris 06, UMR S 1127, CNRS UMR 7225, ICM, 75013 Paris, France; AP-HP, Hôpital Saint-Antoine, 75012 Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, 75013 Paris, France; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Presse Medicale (Paris, France : 1983)
|March 31, 2015
PubMed
Summary

Advanced imaging techniques like quantitative magnetic resonance (MR) and positron emission tomography (PET) offer new insights into multiple sclerosis (MS) by measuring myelin damage, neurodegeneration, and neuroinflammation, aiding drug development.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.8K

Related Experiment Videos

Last Updated: Apr 15, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.2K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K
Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
08:05

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

9.8K

Area of Science:

  • Neuroimaging in Multiple Sclerosis (MS)
  • Quantitative Magnetic Resonance (MR) and Positron Emission Tomography (PET) Technologies

Background:

  • Conventional MR imaging lacks specificity for central nervous system tissue damage in MS.
  • This limits the investigation of key mechanisms like myelin damage/repair, neurodegeneration, and neuroinflammation.
  • Understanding these mechanisms is crucial for addressing neurological disability in MS.

Purpose of the Study:

  • To review the evidence for quantitative MR and PET as essential tools in MS research.
  • To explore their utility in investigating myelin changes, neuronal damage, and inflammation.
  • To highlight their potential for improving clinical trials and drug development for MS.

Main Methods:

  • Summarizing evidence on novel quantitative MR and PET imaging tools.
  • Analyzing their application in experimental MS models and human patients.
  • Correlating imaging metrics with clinical scores.

Main Results:

  • Quantitative MR and PET provide unique insights into MS disease mechanisms.
  • These advanced techniques yield imaging metrics that significantly correlate with clinical scores.
  • They enable exploration of myelin changes, neuronal damage, and compartmentalized inflammation.

Conclusions:

  • Quantitative MR and PET are essential for exploring MS pathology.
  • Clinical translation of these techniques can enhance future clinical trial design.
  • They offer potential for measuring the efficacy of new MS therapies targeting repair and reducing damage.